Patients with HCM are talking to their cardiologists
about advances
in treatment options
is a serious heart condition affecting anywhere from 1 in 500 people,* to as many as
*The 1995 CARDIA study, a multicenter, US-population-based echocardiography study of 4111 subjects (aged 23-35), identified the prevalence of HCM as 1:500 people in the general population.
†The 2015 Semsarian publication identified that the prevalence of HCM gene carriers could be as high as 1:200.
Medication that
treats symptoms
Beta blockers, calcium channel blockers,
and/or disopyramide.
Commonly used to help treat the
symptoms of HCM but most are not FDA
approved for this use.
Surgery that
treats obstruction
Septal reduction therapy includes alcohol
septal ablation and septal myectomy.
Used for severe obstruction or when
HCM continues to worsen even
with medication.
Medication that treats symptoms and obstruction
A treatment option that works inside the heart
muscle to treat HCM.
FDA approved to treat symptomatic obstructive HCM.
Nicole was still short of breath on a
beta
blocker so she did her research
and asked
her cardiologist about
advances in HCM.
If you have been diagnosed with obstructive HCM and still have
symptoms on your current treatment, talk to your cardiologist.
Find out what treatment advances may be out there for you.